// App-Quantinova.ai

E028 : Rituximab biosimilar and miliary tuberculosis: vigilance is the key

Researchers

Presenter

  • Muhammad K Nisar

Principal Investigators

  • N/A

Medical Centers

  • Rheumatology, Luton & Dunstable University Hospital, Luton, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab biosimilar

  • Rituximab-abbs

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved